Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0

Verify with FDA CVM →

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
5
Deaths Reported
4170.0%
Death Rate

Active Ingredients

Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0

Administration Routes

IntramuscularUnknownSubcutaneous

Species Affected

Cattle 10
Unknown 2

Most Affected Breeds

Cattle (other) 4
Unknown 2
Jersey 2
Holstein-Friesian also known as Holstein 2
Mixed (Cattle) 2

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 3
Abortion 3
Uncoded sign 2
Death 2
Vials, Damaged 1
Urticaria 1
Sudden death 1
Color, Abnormal 1
Insert, Abnormal 1
Weakness 1
Musculoskeletal disorder NOS 1
Other abnormal test result NOS 1

Outcome Breakdown

Outcome Unknown
6 (40.0%)
Died
5 (33.3%)
Recovered/Normal
3 (20.0%)
Ongoing
1 (6.7%)

Data Summary

Metric Value
Total adverse event reports 12
Reports involving death 5
Case-fatality rate (reported events) 4170.0%
Distinct species in reports 2
Distinct breeds in reports 5
Distinct reactions reported 18
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12 adverse event reports referencing Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0, including 5 reports in which the animal died — a 4170.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0. Reported administration routes include Intramuscular, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0 reports are Cattle (10 reports), Unknown (2 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (4), Unknown (2), Jersey (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0 are Lack of efficacy (bacteria) - NOS (3), Abortion (3), Uncoded sign (2), Death (2). Of the 15 reports with a coded outcome, Outcome Unknown is the leading category at 40.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Bovine Coronavirus, St Lot 28, 10-17-83, Hansen Isolate; Bovine Rotavirus, Lot 0.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial